**Core Concept**
The hepatotoxicity of certain drugs can be attributed to their ability to induce cellular damage, oxidative stress, or mitochondrial dysfunction in the liver. This can lead to liver enzyme elevation, steatosis, or even fulminant hepatic failure in severe cases.

**Why the Correct Answer is Right**
The correct answer is a well-known hepatotoxic agent that can cause liver enzyme elevation, particularly ALT and AST, in a dose-dependent manner. This is due to its ability to cause mitochondrial damage and oxidative stress in hepatocytes. The mechanism involves the generation of reactive oxygen species (ROS) and disruption of mitochondrial membrane potential, ultimately leading to cell death.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not a well-documented hepatotoxic agent. While it may have other side effects, it is not commonly associated with liver damage.

**Option B:** This option is incorrect because it is actually used to treat liver disease, particularly fatty liver disease. It works by inhibiting diacylglycerol acyltransferase 2 (DGAT2), an enzyme involved in triglyceride synthesis.

**Option C:** This option is incorrect because it is not typically associated with hepatotoxicity. Its side effect profile is more commonly related to gastrointestinal upset and allergic reactions.

**Clinical Pearl / High-Yield Fact**
When prescribing hepatotoxic agents, it's essential to monitor liver enzymes regularly, especially in patients with pre-existing liver disease or those taking other hepatotoxic medications. A commonly used mnemonic to remember hepatotoxic agents is "STAT": "Statins" (e.g., atorvastatin), "Tetracyclines" (e.g., doxycycline), "Acetaminophen", and "Ticlopidine".

**Correct Answer:** B. Amiodarone